Skip to main content
CLBCore Laboratories Inc.Sell4.8·$11.26+3.40%
SellModerate Confidence
Investment thesis

Core Laboratories offers an attractive valuation and strong cash conversion, but declining revenue, a failed momentum gate, and justified elevated short interest reflect real near-term operating headwinds.

Thesis pillars

  • Earnings Beat Streak CatalystStable
  • Attractive Valuation Strong Cash ConversionStable
  • Declining Revenue And Failed MomentumStable
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Core Laboratories Inc. (CLB) Stock Analysis

Catalyst-Driven edge

SellVALUE-TRAP 1/5ShortModerate Confidence

Energy · Oil & Gas Equipment & Services

Sell if holding. Momentum 2.7/10 is below the 5.0 floor at $11.26 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.8/10; Weak growth.

We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major,... Read more

$11.26+19.6% A.UpsideScore 4.8/10#33 of 37 Oil & Gas Equipment & Services
QualityF-score7 / 9FCF yield8.65%
IncomeYield0.35%(5y avg 0.22%)Payout6.56%sustainable
Stop $10.46Target $13.46(analyst − 15%)A.R:R 1.9:1
Analyst target$15.83+40.6%3 analysts
$13.46our TP
$11.26price
$15.83mean
$22

Sell if holding. Momentum 2.7/10 is below the 5.0 floor at $11.26 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.8/10; Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Score 4.8/10, moderate confidence.

Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 22d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: speculative.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 202622d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Weak overall score: 4.8/10
Weak growth
Negative momentum

Key Metrics

P/E (TTM)18.2
P/E (Fwd)16.0
Mkt Cap$511M
EV/EBITDA10.9
Profit Mgn5.5%
ROE11.1%
Rev Growth-1.4%
Beta1.01
Dividend0.35%
Rating analysts10

Quality Signals

Piotroski F7/9

Options Flow

P/C1.06bearish
IV94%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
3.5
Macd
6.9
Volume distribution (falling OBV)Below 200-MA but MA still rising (+1.0%/30d) — pullback in uptrend, not confirmed weakness

Revenue shrinking — -1.4% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
2.1
Earnings Growth
4.8
Declining revenue: -1%
GatesMomentum 2.7<4.5A.R:R 1.9 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 22d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Speculative
RSI
39 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.51Resistance $13.95

Price Targets

$10
$13
A.Upside+19.5%
A.R:R1.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 2.7 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (22d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLB stock a buy right now?

Sell if holding. Momentum 2.7/10 is below the 5.0 floor at $11.26 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.8/10; Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $10.46. Score 4.8/10, moderate confidence.

What is the CLB stock price target?

Take-profit target: $13.46 (+19.6% upside). Prior stop was $10.46. Stop-loss: $10.46.

What are the risks of investing in CLB?

Weak overall score: 4.8/10; Weak growth; Negative momentum.

Is CLB overvalued or undervalued?

Core Laboratories Inc. trades at a P/E of 18.2 (forward 16.0). TrendMatrix value score: 7.3/10. Verdict: Sell.

What do analysts say about CLB?

10 analysts cover CLB with a consensus score of 2.4/5. Average price target: $16.

What does Core Laboratories Inc. do?We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir...

We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields.

Related stocks: FLOC (Flowco Holdings Inc.) · NGS (Natural Gas Services Group, Inc) · WHD (Cactus, Inc. Class A Common Sto) · USAC (USA Compression Partners, LP) · VTOL (Bristow Group, Inc.)
Home Stocks CLB

Latest news

No recent news